U.S. FDA approves orphan drug MyaleptTM (metreleptin for injection)

[Business Wire] – AstraZeneca today announced that the U.S. Food and Drug Administration has approved Myaleptâ„¢ , which is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital more

View todays social media effects on AZN

View the latest stocks trending across Twitter. Click to view dashboard

See who Astrazeneca is hiring next, click here to view